Article Information
History
- July 29, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Marilyne Labrie1,2,*,
- Allen Li1,
- Allison Creason3,
- Courtney Betts2,
- Jamie Keck1,6,
- Brett Johnson1,6,7,
- Shamilene Sivagnanam1,3,
- Christopher Boniface4,
- Hongli Ma1,2,
- Aurora Blucher1,2,
- Young Hwan Chang3,6,7,
- Koei Chin6,7,
- Jacqueline Vuky1,
- Alexander R. Guimaraes1,5,
- Molly Downey5,
- Jeong Youn Lim1,
- Lina Gao1,
- Kiara Siex1,
- Swapnil Parmar1,
- Annette Kolodzie1,6,
- Paul T Spellman1,4,6,
- Jeremy Goecks3,
- Lisa M. Coussens1,2,
- Christopher L. Corless1,8,
- Raymond Bergan1,
- Joe W. Gray1,6,7,
- Gordon B. Mills1,2,9 and
- Zahi I. Mitri1,*
- 1Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA
- 2Department of Cell, Developmental & Cancer Biology, Oregon Health and Science University, Portland, United States
- 3Computational Biology Program, Oregon Health and Science University, Portland, OR, United States
- 4Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, United States
- 5Department of Diagnostic Radiology, Oregon Health and Science University, Portland, OR, USA
- 6Center for Spatial Systems Biomedicine (OCSSB), Oregon Health and Science University, Portland, United States
- 7Department of Biomedical Engineering, Oregon Health and Science University, Portland, United States
- 8Department of Pathology, Oregon Health and Science University, Portland, United States
- 9Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas USA
- ↵*Corresponding authors
: Zahi I. Mitri, MD, MS, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd., Mail Code: OC14HO, Portland, OR 97239, E-mail: mitri{at}ohsu.edu, Marilyne Labrie, PhD, Oregon Health & Science University, 2720 S Moody Avenue, Mailcode: KR-PM, Portland, OR 97201, E-mail: labriem{at}ohsu.edu
Posted July 29, 2020.
Multi-omics analysis of serial samples from metastatic TNBC patients on PARP inhibitor monotherapy provide insight into rational PARP inhibitor therapy combinations
